Immunovant, Inc. (IMVT)
NASDAQ: IMVT · IEX Real-Time Price · USD
26.52
-0.99 (-3.60%)
At close: Jul 2, 2024, 4:00 PM
26.02
-0.50 (-1.89%)
After-hours: Jul 2, 2024, 7:56 PM EDT
Immunovant Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for Immunovant stock have an average target of 47.93, with a low estimate of 32 and a high estimate of 57. The average target predicts an increase of 80.73% from the current stock price of 26.52.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 3, 2024.
Analyst Ratings
The average analyst rating for Immunovant stock from 16 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 10 | 10 | 9 | 9 |
| Buy | 5 | 6 | 7 | 7 | 7 | 7 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 16 | 18 | 18 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 18, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $50 → $46 | Buy | Maintains | $50 → $46 | +73.45% | Jun 3, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +92.31% | May 30, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
90.58M
EPS This Year
-2.24
from -1.88
EPS Next Year
-2.42
from -2.24
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 549.1M | 616.7M | 1.7B | 2.8B |
| Avg | n/a | 90.6M | 276.9M | 721.4M | 1.3B |
| Low | n/a | n/a | 27.9M | 102.2M | 369.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 580.8% | 514.3% | 283.6% |
| Avg | - | - | 205.7% | 160.5% | 73.7% |
| Low | - | - | -69.2% | -63.1% | -48.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.99 | -1.79 | 0.22 | 2.49 | 5.17 |
| Avg | -2.24 | -2.42 | -2.01 | -0.66 | 1.14 |
| Low | -2.56 | -2.82 | -3.00 | -1.98 | -0.98 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.